Trulieve Cannabis Corp Stock Price To Sales
| TCNNF Stock | USD 12.15 0.05 0.41% |
Trulieve Cannabis Corp fundamentals help investors to digest information that contributes to Trulieve Cannabis' financial success or failures. It also enables traders to predict the movement of Trulieve OTC Stock. The fundamental analysis module provides a way to measure Trulieve Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Trulieve Cannabis otc stock.
Trulieve |
Trulieve Cannabis Corp OTC Stock Price To Sales Analysis
Trulieve Cannabis' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Trulieve Cannabis Price To Sales | 1.26 X |
Most of Trulieve Cannabis' fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Trulieve Cannabis Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Trulieve Cannabis Corp has a Price To Sales of 1.2632 times. This is 94.1% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is 88.94% higher than that of the company.
Trulieve Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Trulieve Cannabis' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Trulieve Cannabis could also be used in its relative valuation, which is a method of valuing Trulieve Cannabis by comparing valuation metrics of similar companies.Trulieve Cannabis is currently under evaluation in price to sales category among its peers.
Trulieve Cannabis ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Trulieve Cannabis' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Trulieve Cannabis' managers, analysts, and investors.Environmental | Governance | Social |
Trulieve Fundamentals
| Return On Equity | -0.14 | |||
| Return On Asset | 0.0479 | |||
| Profit Margin | (0.19) % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 2.48 B | |||
| Shares Outstanding | 159.64 M | |||
| Shares Owned By Insiders | 8.76 % | |||
| Shares Owned By Institutions | 12.51 % | |||
| Price To Earning | 23.96 X | |||
| Price To Book | 0.83 X | |||
| Price To Sales | 1.26 X | |||
| Revenue | 938.38 M | |||
| Gross Profit | 607.32 M | |||
| EBITDA | 276.51 M | |||
| Net Income | 18.03 M | |||
| Cash And Equivalents | 114.47 M | |||
| Cash Per Share | 0.62 X | |||
| Total Debt | 469.38 M | |||
| Debt To Equity | 0.47 % | |||
| Current Ratio | 3.28 X | |||
| Book Value Per Share | 10.82 X | |||
| Cash Flow From Operations | 12.9 M | |||
| Earnings Per Share | (0.29) X | |||
| Target Price | 22.04 | |||
| Number Of Employees | 8 K | |||
| Beta | 1.72 | |||
| Market Capitalization | 1.15 B | |||
| Total Asset | 3.41 B | |||
| Z Score | 1.2 | |||
| Net Asset | 3.41 B |
About Trulieve Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Trulieve Cannabis Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Trulieve Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Trulieve Cannabis Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| OEF | iShares SP 100 | |
| GLD | SPDR Gold Shares | |
| OIH | VanEck Oil Services | |
| IBB | iShares Biotechnology ETF | |
| IJH | iShares Core SP |
Other Information on Investing in Trulieve OTC Stock
Trulieve Cannabis financial ratios help investors to determine whether Trulieve OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Trulieve with respect to the benefits of owning Trulieve Cannabis security.